Sign in to view content

A Model to Predict the 3-Year Risk of Needing Treatment for Diabetic Macular Edema

Bobeck S Modjtahedi, MD

Video
Published 2018

Related

Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Therapies for Diabetic Macular Edema: What’s in the Pipeline?
Peter K. Kaiser, MD FASRS
Updates from the Field
2018
Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)
Keyvan Koushan, MD, FRCSC
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more